Cancer: The nuances of therapy

Nature

Volumn 458, Issue 7236, 2009, Pages

  Ellis, Lee M ^a   Reardon, David A ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; IRINOTECAN; VASCULOTROPIN INHIBITOR;

BLOOD; CANCER; DISEASE TREATMENT; DRUG;

ANGIOGENESIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; GLIOBLASTOMA; HUMAN; KIDNEY CANCER; LIVER CELL CARCINOMA; METASTASIS; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SHORT SURVEY; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 62649101158     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/458290a     Document Type: Short Survey

References (12)

1. Pàez-Ribes, M. et al. Cancer Cell 15, 220-231 (2009).
2. Ebos, J. M. L. et al. Cancer Cell 15, 232-239 (2009).
3. Ellis, L. M. & Hicklin, D. J. Nature Rev. Cancer 8, 579-591 (2008).
4. Ferrara, N. et al. Nature 380, 439-442 (1996).
5. Lee, S. et al. Cell 130, 691-703 (2007).
6. Ebos, J. M. L. et al. Proc. Natl Acad. Sci. USA 104, 17069-17074 (2007).
7. Du, R. et al. Cancer Cell 13, 206-220 (2008).
8. Grothey, A. et al. J. Clin. Oncol. 26, 5326-5334 (2008).
9. Escudier, B. et al. N. Engl. J. Med. 356, 125-134 (2007).
10. Llovet, J. M. et al. N. Engl. J. Med. 359, 378-390 (2008).
11. Vredenburgh, J. J. et al. J. Clin. Oncol. 25, 4722-4729 (2007).
12. Kopetz, S. et al. Proc. 2009 Gastrointest. Cancers Symp. Abstr. 292 (Am. Soc. Clin. Oncol., 2009).